Clinical Research Directory
Browse clinical research sites, groups, and studies.
Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Open Label
Sponsor: Stanford University
Summary
The goal of this study is to target the neurobiology of restricted and repetitive behaviors in children with autism spectrum disorder using N-acetylcysteine (NAC), a well-tolerated nutritional supplement that has shown promise for reducing symptom severity in recent small-scale trials. The findings from this research will shed light on the mechanisms of action underlying the clinical benefits of NAC and the effects of NAC on altering restricted and repetitive behavior symptom severity in children with autism spectrum disorder.
Official title: Targeting the Neurobiology of Restricted and Repetitive Behaviors in Children With Autism Using N-acetylcysteine: an Open Label Extension
Key Details
Gender
All
Age Range
3 Years - 13 Years
Study Type
INTERVENTIONAL
Enrollment
144
Start Date
2024-03-12
Completion Date
2029-01-31
Last Updated
2026-01-20
Healthy Volunteers
No
Conditions
Interventions
N-acetylcysteine
12 week administration of N-Acetylcysteine to target restricted repetitive behavior severity.
Locations (1)
Stanford University School of Medicine
Stanford, California, United States